Sonnet BioTherapeutics

1 follower

‌

Sonnet’s proprietary FHAB™ (Fully Human Albumin Binding) technology enables the development of innovative targeted biologic drugs with enhanced single- or bi-specific mechanisms.

Industries

Headquarters

Employees

Links

Org chart

Pankaj Mohan

Founder, CEO & Chairman

Pankaj Mohan

Collapse

John K. Cini

Chief Scientific Officer & Co Founder

Jay Cross

CFO

Susan Dexter

Chief Technical Officer

Richard Kenney

Chief Medical Officer

Stephen J. McAndrew

Vice President, Business Development

Kal Ghosh

Executive Administrative Assistant

Teams

Directors

5 members

Leadership Team

5 members

Advisory Team

4 members

Similar companies

Emergent BioSolutions

4 followers

Owkin

4 followers

Synthekine

3 followers

GOURMEY

19 followers

Forge Biologics

2 followers

Obsidian Therapeutics

1 follower

MassBio

1 follower

PMV Pharmaceuticals

1 follower

Generate Biomedicines

3 followers

Spark Capital

20 followers

UNC Charlotte

6 followers

Discover companies